Initiation of sodium-glucose co-transporter-2 inhibitors in patients with heart failure in the acute medical setting

Back

HFA Premium Access

Initiation of sodium-glucose co-transporter-2 inhibitors in patients with heart failure in the acute medical setting

Session: ePosters in chronic heart failure - pharmacotherapy 4

Topic: Pharmacotherapy

Speaker: Doctor T. Furlan (Trbovlje, SI)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tjasa Furlan

Trbovlje General Hospital, Trbovlje (Slovenia)

0 follower

7 more presentations in this session

Medication optimisation after acute heart failure hospitalisation: a current situation in a developing country

Speaker: Doctor K. Lorlowhakarn (Bangkok, TH)

Applicability of vericiguat in heart failure patients early post-discharge: a single-center study

Speaker: Doctor M. Passos (Amadora, PT)

Impact of statins on mortality and re-hospitalization in acute heart failure patients

Speaker: Doctor R. Rajan (Kuwait, KW)

The eligibility of patients hospitalized for heart failure for rapid up-titration of guideline-directed medical therapy in the light of the STRONG-HF trial and the latest ESC heart failure guidelines

Speaker: Doctor F. Banfi-Bacsardi (Budapest, HU)

Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on hypotension, titration and drug combination

Speaker: Doctor M. Chou (Tainan, TW)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 4

Speakers: Doctor T. Furlan, Doctor K. Lorlowhakarn, Doctor M. Passos, Doctor R. Rajan, Doctor F. Banfi-Bacsardi...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources